Characteristics of Dupilumab-Treated Patients with Atopic Dermatitis Over Time: A Cross-Sectional Assessment of Potential Channeling Bias upon Pediatric Label Extension - Top-Institutions - MDSpire

Characteristics of Dupilumab-Treated Patients with Atopic Dermatitis Over Time: A Cross-Sectional Assessment of Potential Channeling Bias upon Pediatric Label Extension

  • By

  • Julie Barberio

  • Venkatesh Harikrishnan

  • Shiyao Gao

  • Andrea Marcus

  • Sarah-Jo Sinnott

  • July 18, 2026

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai

    New York, NY

    Key Differentiators

    • Dermatology

  • #2

    Northwestern University Feinberg School of Medicine
    Northwestern University Feinberg School of Medicine

    Chicago, IL

    Key Differentiators

    • Dermatology

Original Source(s)

Characteristics of Dupilumab-Treated Patients with Atopic Dermatitis Over Time: A Cross-Sectional Assessment of Potential Channeling Bias upon Pediatric Label Extension

  • by Julie Barberio, Venkatesh Harikrishnan, Shiyao Gao, Andrea Marcus, Sarah-Jo Sinnott

  • July 18, 2026

Related Content

FDA Approves New Oral Option for Plaque Psoriasis

Phase 3 data showed high skin clearance rates and adverse event rates similar to placebo through week 16 with once-daily icotrokinra.

From Sophie Spitz to Molecular Melanocytoma

How one woman's pioneering research transformed pediatric melanoma diagnosis

Side Effects: Turns Out, Never Mind

Red meat didn't wreck the pancreas. Sauna doesn't do what we thought. Loneliness doesn't accelerate decline. A week of quietly overturned assumptions.